Atrial septal defect (ASD) is a common congenital heart defect. Transcatheter closure become now the standard approach for ostium secondum type ASD closure against surgery. However, this procedure is not free of complications Device migration is the most common complication. We report a case of an obstruction of tricuspid valve by migration of a transcatheter ASD device occlude in a 9 years-old girl reveled by severe ventricular arrhythmias. She underwent successful emergent surgical removal under cardiopulmonary bypass and ASD closure with a synthetic patch. The postoperative course was favorable.
Introduction
Atrial septal defect (ASD) is a common congenital heart defect, it represent 10-15% of all cardiovascular malformation [1] . Surgery has been considered to be the gold standard treatment of ASD since the late 1960s with good long term postoperative results [2] . The first transcatheter closure of ASD was conducted by King and Mills in 1976 [3] , it become now the standard approach for ostium secundum type ASD closure because it is technically simple and associated with low mortality and morbidity, as well as shorter hospital stay and recovery. However, several studies have reported a post-procedural in-hospital complication rate ranging from 1.2 -8.7%. Device migration is the most common complication [2, 4, 5, 6 ] percutaneous device retrieval is not possible in most cases and surgical removal is necessary. We report a case of an obstruction of tricuspid valve by migration of a transcatheter ASD device occluder reveled by a severe ventricular arrhythmia. 
Observation
We report an observation of a 9 year-old girl referred for an cardiac murmur. Clinical examination found a child in good health weighing 22 kg. The cardiac auscultation found a 2/6 pulmonic ejection systolic murmur associated with a duplicated second pulmonary sound. The transthoracic echocardiography (TTE) reported an ostium secondum ASD measuring 15.3x18. 
Discussion
Atrial septal defect (ASD) is the third most common congenital heart disease and accounts for approximately 6% to 10% of all congenital cardiac defects [7] . Surgery has been considered to be the standard treatment of ASD for several decades with high success rate, low mortality and good long term postoperative results [8] . Amplatzer septal occluder (ASO) has become the most commonly used device [9] . It offers the advantage that it obviates thoracotomy scars and open heart surgery. Recent studies emphasizes that trans-catheter closure is a safe method with shorter hospital stay, less mortality and morbidity rates [10] . However, this procedure is not free of complications. Device embolization is the most frequent major complication after ASO. In the literature, embolization rates were high ranging from 4% to 20%, actually it decreased between 0.55 and 2% with new generation devices [9] .
Embolization of the device may occur in intra-cardiac sites (left atrium, right atrium, left ventricle or right ventricle)
or extra-cardiac sites such pulmonary and aortic arteries and may cause serious damages.
Clinical presentation is depending of device embolization site. In the majority of cases, device embolization is asymptomatic. In our case, the clinical manifestation was a severe ventricular arrhythmia because of the location in the right ventricle [3, 4] .
The principal cause of device embolization is the inadequate defect rim to hold the device or tearing of the interatrial septum especially at the lower rim of the ASD owing to catheter and device manipulations. Several study report that larger ASD (> 20 mm) and device size (> 24 mm) were the most predictors factors related to device embolization which were seen in our patient [5] . Misra M et al. [11] reports that small or deficient aortic rim is often ignored with newer self-centering devices. However, a margin less than 5mm may predispose to early and late device embolization. Others reports have showed a deficient aortic rim in the majority of cases associated with embolization or displacement of the device. [2, 5] Currently no guidelines exist for device embolization management. Several studies report a successful percutaneous retrieval of embolized device when the embolization site occurs in extracardiac. Moreover, in intracardiac embolization, percutaneous retrieval attempts may cause intracardiac structure damage particularly at valvular and subvalvular apparatus. Gokhan Gokaslan [9] report tricuspid septal leaflet chordae injury in two cases and posterior leaflet septal commissural damage in one case needing surgical repair. We believe that surgical intervention is a secure option for management of intracardiac embolization particularly when patient is symptomatic, as our case.
We preferred emergency intervention because of the localization of the embolized device in tricuspid valve and the presence of ventricular arrhythmia.
Conclusion
Our case showed that transcatheter atrial septal occlude is not without risk. Device embolization is the most frequent complication. It can be reveled by severing clinical manifestation, such as ventricular arrhythmia, related to the immobilized device location. Surgical management is a secure option in intracardiac embolization in absent of guidelines for device embolization management.
